Updated interpretation of Impedance–pH monitoring

Authors

DOI:

https://doi.org/10.22516/25007440.608

Keywords:

pH-impedance monitoring, Gastroesophageal reflux disease, Proton-pump inhibitor

Abstract

Gastroesophageal reflux disease (GERD) is defined as the abnormal transit of gastric contents into the esophagus. It is caused by an alteration of the anti-reflux barrier, causing multiple symptoms or complications. In order to achieve accurate diagnosis and proper therapeutic approach, integration of clinical findings, endoscopic findings and 24-hour esophageal pH monitoring, with or without impedancometry, is required. These tests must be performed following technical specifications and their interpretation must be based on the best clinical evidence available to obtain accurate diagnoses that allow making the best decisions to the benefit of patients.

Recently, the Lyon Consensus incorporated new guidelines for the diagnosis of GERD by esophageal pH monitoring, which are reviewed in this paper.

Downloads

Download data is not yet available.

Author Biographies

Valeria Atenea Costa, Hospital Universitario San Ignacio

Internista, Gastroenterologa 

Areas  de  interes : VCE/enteroscopia/CPRE/ fisiologia  digestiva

Oscar Mariano Pinto Saavedra, Pontificia Universidad Javeriana

Médico Internista Fellow de Gastroenterología.

Albis Cecilia Hani Amador, Pontificia Universidad Javeriana

Médico Internista y Gastroenteróloga. Profesora Titular  Pontificia Universidad Javeriana. Bogotá

Ana María Leguízamo Naranjo, Pontificia Universidad Javeriana

Médico Internista y Gastroenteróloga. Profesor Ad Honorem. Bogotá

Andrés Felipe Ardila Hani, Pontificia Universidad Javeriana

Médico internista y gastroenterólogo. Profesor Ad Honorem Pontificia Universidad Javeriana. Hospital Universitario San Ignacio

References

Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R; Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101(8):1900-20; quiz 1943. https://doi.org/10.1111/j.1572-0241.2006.00630.x

Patti MG. An Evidence-Based Approach to the Treatment of Gastroesophageal Reflux Disease. JAMA Surg. 2016;151(1):73-8. https://doi.org/10.1001/jamasurg.2015.4233

Cesario S, Scida S, Miraglia C, Barchi A, Nouvenne A, Leandro G, Meschi T, De’ Angelis GL, Di Mario F. Diagnosis of GERD in typical and atypical manifestations. Acta Biomed. 2018;89(8-S):33-39. https://doi.org/10.23750/abm.v89i8-S.7963

Yadlapati R, Pandolfino JE. Personalized Approach in the Work-up and Management of Gastroesophageal Reflux Disease. Gastrointest Endosc Clin N Am. 2020;30(2):227-238. https://doi.org/10.1016/j.giec.2019.12.002

Gyawali CP, Kahrilas PJ, Savarino E, Zerbib F, Mion F, Smout AJPM, Vaezi M, Sifrim D, Fox MR, Vela MF, Tutuian R, Tack J, Bredenoord AJ, Pandolfino J, Roman S. Modern diagnosis of GERD: the Lyon Consensus. Gut. 2018;67(7):1351-1362. https://doi.org/10.1136/gutjnl-2017-314722

Chen J, Brady P. Gastroesophageal Reflux Disease: Pathophysiology, Diagnosis, and Treatment. Gastroenterol Nurs. 2019;42(1):20-28. https://doi.org/10.1097/SGA.0000000000000359

El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014;63(6):871-80. https://doi.org/10.1136/gutjnl-2012-304269

Páramo-Hernández DB, Albis R, Galiano MT, de Molano B, Rincón R, Pineda-Ovalle LF, Rodríguez A, Otero-Regino W, Hani A, Sabbagh LC, Sandoval-Salinas C, Sánchez-Pedraza R. Prevalencia de síntomas del reflujo gastroesofágico y factores asociados: una encuesta poblacional en las principales ciudades de Colombia. Rev Col Gastroenterol. 2016;31(4):337-346.

Roman S, Gyawali CP, Savarino E, Yadlapati R, Zerbib F, Wu J, Vela M, Tutuian R, Tatum R, Sifrim D, Keller J, Fox M, Pandolfino JE, Bredenoord AJ; GERD consensus group. Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus group. Neurogastroenterol Motil. 2017;29(10):1-15. https://doi.org/10.1111/nmo.13067

Hong SK, Vaezi MF. Gastroesophageal reflux monitoring: pH (catheter and capsule) and impedance. Gastrointest Endosc Clin N Am. 2009;19(1):1-22, v. https://doi.org/10.1016/j.giec.2008.12.009

Hobbs P, Gyawali CP. The role of esophageal pH-impedance testing in clinical practice. Curr Opin Gastroenterol. 2018;34(4):249-257. https://doi.org/10.1097/MOG.0000000000000441

Ribolsi M, Giordano A, Guarino MPL, Tullio A, Cicala M. New classifications of gastroesophageal reflux disease: an improvement for patient management? Expert Rev Gastroenterol Hepatol. 2019;13(8):761-769. https://doi.org/10.1080/17474124.2019.1645596

Neto RML, Herbella FAM, Schlottmann F, Patti MG. Does DeMeester score still define GERD? Dis Esophagus. 2019;32(5):doy118. https://doi.org/10.1093/dote/doy118

Mainie I, Tutuian R, Shay S, Vela M, Zhang X, Sifrim D, Castell DO. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut. 2006;55(10):1398-402. https://doi.org/10.1136/gut.2005.087668

Aziz Q, Fass R, Gyawali CP, Miwa H, Pandolfino JE, Zerbib F. Esophageal disorders. Gastroenterology. 2016;150(6):1368-79. https://doi.org/10.1053/j.gastro.2016.02.012

Savarino V, Marabotto E, Zentilin P, Furnari M, Bodini G, De Maria C, Tolone S, De Bortoli N, Frazzoni M, Savarino E. Pathophysiology, diagnosis, and pharmacological treatment of gastro-esophageal reflux disease. Expert Rev Clin Pharmacol. 2020;13(4):437-449. https://doi.org/10.1080/17512433.2020.1752664

Hani de Ardila Albis. Pruebas diagnósticas en enfermedad por reflujo gastroesofágico (ERGE). Rev Col Gastroenterol. 2009;24(2):210-222.

Helgadottir H, Bjornsson ES. Problems Associated with Deprescribing of Proton Pump Inhibitors. Int J Mol Sci. 2019;20(21):5469. https://doi.org/10.3390/ijms20215469

Lødrup AB, Reimer C, Bytzer P. Systematic review: symptoms of rebound acid hypersecretion following proton pump inhibitor treatment. Scand J Gastroenterol. 2013;48(5):515-22. https://doi.org/10.3109/00365521.2012.746395

Waldum HL, Qvigstad G, Fossmark R, Kleveland PM, Sandvik AK. Rebound acid hypersecretion from a physiological, pathophysiological and clinical viewpoint. Scand J Gastroenterol. 2010;45(4):389-94. https://doi.org/10.3109/00365520903477348

Figura 2. Catéter de pH-impedanciometría (un sensor de pH y 8 sensores de impedanciometría)

Published

2021-03-08

How to Cite

Costa, V. A., Pinto Saavedra, O. M., Hani Amador, A. C., Leguízamo Naranjo, A. M., & Ardila Hani, A. F. (2021). Updated interpretation of Impedance–pH monitoring. Revista Colombiana De Gastroenterología, 36(1), 73–80. https://doi.org/10.22516/25007440.608

Issue

Section

Review articles

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
QR Code

Some similar items: